Cargando…

Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study

Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 39...

Descripción completa

Detalles Bibliográficos
Autores principales: Lutz, Bárbara Heather, Bassani, Diego Garcia, Miranda, Vanessa Iribarrem Avena, Silveira, Marysabel Pinto Telis, Mengue, Sotero Serrate, Dal Pizzol, Tatiane da Silva, da Silveira, Mariângela Freitas, Bertoldi, Andréa Dâmaso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014443/
https://www.ncbi.nlm.nih.gov/pubmed/31963112
http://dx.doi.org/10.3390/ijerph17020568
_version_ 1783496631541301248
author Lutz, Bárbara Heather
Bassani, Diego Garcia
Miranda, Vanessa Iribarrem Avena
Silveira, Marysabel Pinto Telis
Mengue, Sotero Serrate
Dal Pizzol, Tatiane da Silva
da Silveira, Mariângela Freitas
Bertoldi, Andréa Dâmaso
author_facet Lutz, Bárbara Heather
Bassani, Diego Garcia
Miranda, Vanessa Iribarrem Avena
Silveira, Marysabel Pinto Telis
Mengue, Sotero Serrate
Dal Pizzol, Tatiane da Silva
da Silveira, Mariângela Freitas
Bertoldi, Andréa Dâmaso
author_sort Lutz, Bárbara Heather
collection PubMed
description Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 3988). Medications were classified according to Hale’s lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Results: Medication use with some risk for lactation was frequent (79.6% regarding Hale’s risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant differences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Conclusions: Our study found no association between weaning rates across the different breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-effects associated with medications could not be addressed in this analysis.
format Online
Article
Text
id pubmed-7014443
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70144432020-03-09 Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study Lutz, Bárbara Heather Bassani, Diego Garcia Miranda, Vanessa Iribarrem Avena Silveira, Marysabel Pinto Telis Mengue, Sotero Serrate Dal Pizzol, Tatiane da Silva da Silveira, Mariângela Freitas Bertoldi, Andréa Dâmaso Int J Environ Res Public Health Article Background: This study describes medication use by women up to 3 months postpartum and evaluates the association between medication use by women who were still breastfeeding at 3 months postpartum and weaning at 6 and 12 months. Methods: Population-based cohort, including women who breastfed (n = 3988). Medications were classified according to Hale’s lactation risk categories and Brazilian Ministry of Health criteria. Duration of breastfeeding was analysed using Cox regression models and Kaplan-Meier curves, including only women who were still breastfeeding at three months postpartum. Results: Medication use with some risk for lactation was frequent (79.6% regarding Hale’s risk categories and 12.3% regarding Brazilian Ministry of Health criteria). We did not find statistically significant differences for weaning at 6 or 12 months between the group who did not use medication or used only compatible medications and the group who used medications with some risk for lactation, according to both criteria. Conclusions: Our study found no association between weaning rates across the different breastfeeding safety categories of medications in women who were still breastfeeding at three months postpartum. Therefore, women who took medications and stopped breastfeeding in the first three months postpartum because of adverse side-effects associated with medications could not be addressed in this analysis. MDPI 2020-01-16 2020-01 /pmc/articles/PMC7014443/ /pubmed/31963112 http://dx.doi.org/10.3390/ijerph17020568 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lutz, Bárbara Heather
Bassani, Diego Garcia
Miranda, Vanessa Iribarrem Avena
Silveira, Marysabel Pinto Telis
Mengue, Sotero Serrate
Dal Pizzol, Tatiane da Silva
da Silveira, Mariângela Freitas
Bertoldi, Andréa Dâmaso
Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title_full Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title_fullStr Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title_full_unstemmed Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title_short Use of Medications by Breastfeeding Women in the 2015 Pelotas (Brazil) Birth Cohort Study
title_sort use of medications by breastfeeding women in the 2015 pelotas (brazil) birth cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014443/
https://www.ncbi.nlm.nih.gov/pubmed/31963112
http://dx.doi.org/10.3390/ijerph17020568
work_keys_str_mv AT lutzbarbaraheather useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT bassanidiegogarcia useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT mirandavanessairibarremavena useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT silveiramarysabelpintotelis useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT menguesoteroserrate useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT dalpizzoltatianedasilva useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT dasilveiramariangelafreitas useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy
AT bertoldiandreadamaso useofmedicationsbybreastfeedingwomeninthe2015pelotasbrazilbirthcohortstudy